Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Squamous Cell Carcinoma of Head and Neck 8Oropharyngeal Neoplasms 7Cholangiocarcinoma 7Pancreatic Neoplasms 6Lung Neoplasms 6Urinary Bladder Neoplasms 5Ovarian Neoplasms 4Mouth Neoplasms 4Laryngeal Neoplasms 4Gallbladder Neoplasms 4Carcinoma 4Sarcoma 3Hypopharyngeal Neoplasms 3Fallopian Tube Neoplasms 3Urethral Neoplasms 2Stomach Neoplasms 2Peritoneal Neoplasms 2Paranasal Sinus Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Mesothelioma, Malignant 2Klatskin Tumor 2Colorectal Neoplasms 2Vulvar Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ureteral Neoplasms 1Testicular Neoplasms 1Stomatitis 1

Interventions

lutetium Lu 177 dotatate 29Everolimus 19Temozolomide 11gallium Ga 68 dotatate 10Nivolumab 10Magnetic Resonance Spectroscopy 10Capecitabine 9pembrolizumab 8lanreotide 8Positron Emission Tomography Computed Tomography 8cabozantinib 73-Iodobenzylguanidine 7177Lu-octreotide, DOTA(0)-Tyr(3)- 7Somatostatin 690Y-octreotide, DOTA-Tyr(3)- 6telotristat ethyl 5lenvatinib 5Octreotide 5Lutetium-177 5Ga(III)-DOTATOC 5Fluorodeoxyglucose F18 5Carboplatin 5avelumab 4Positron-Emission Tomography 4Ipilimumab 4Bevacizumab 4surufatinib 3pasireotide 3fluorodopa F 18 3copper dotatate CU-64 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neuroendocrine Tumors × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT02402920 2026-03-10

Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
83 enrolled 13 charts
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡